Target intelligence / Profile preview

Streptococcus pyogenes cell envelope proteinase (SpyCEP)

Target
SpyCEP
Molecular classification
Enzyme, Serine protease, Subtilisin-like protease (subtilase)
01

Overview

Streptococcus pyogenes cell envelope proteinase (SpyCEP), also known as ScpC, is a large surface-exposed serine protease expressed by Group A Streptococcus (GAS). Its primary biological function is the highly specific cleavage and inactivation of CXC chemokines, most notably interleukin-8 (IL-8/CXCL8), which is a potent chemoattractant for neutrophils (Zinkernagel et al., 2008, Cell Host & Microbe). By degrading these signaling molecules, SpyCEP prevents the recruitment of neutrophils to the site of infection, allowing the bacteria to evade the host's innate immune response and disseminate into deeper tissues (Kurupati et al., 2010, Journal of Biological Chemistry). This mechanism is particularly critical in the pathogenesis of severe, invasive infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. As a major virulence factor, SpyCEP is considered a promising therapeutic target for the development of vaccines and neutralizing antibodies aimed at restoring host immune clearance (Turner et al., 2009, Journal of Infectious Diseases). Experimental strategies focus on inhibiting its proteolytic activity to ensure that chemokine gradients remain intact, thereby facilitating an effective inflammatory response against the pathogen.

Other names
ScpCPrtSIL-8 proteaseInterleukin-8-cleaving enzymeSubtilisin-like serine protease
02

Mechanism of action

Inhibition of the protease activity to prevent the cleavage of CXC chemokines like IL-8, thereby restoring neutrophil recruitment to the site of infection.

03

Biological functions

ProteolysisImmune evasionChemokine degradationInhibition of neutrophil recruitment
04

Disease associations

InfectionInvasive Group A Streptococcal diseaseNecrotizing fasciitisToxic shock syndromeSepsis
05

Safety considerations

Potential for cross-reactivity with human proteasesRisk of exacerbating inflammation by restoring chemokine signalingHigh sequence variability in some bacterial strains
06

Interacting drugs

SpyCEP-based vaccines (experimental)

1 more in the full profile.

07

Biomarkers

IL-8 levelsNeutrophil count at infection siteSpyCEP antibody titers

Beyond the preview

Go deeper on Streptococcus pyogenes cell envelope proteinase (SpyCEP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pyogenes cell envelope proteinase (SpyCEP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call